WallStreetZenWallStreetZen

NASDAQ: TBPH
Theravance Biopharma Inc Stock Ownership - Who owns Theravance Biopharma?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Theravance Biopharma Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Rick E. WinninghamCHIEF EXECUTIVE OFFICER2025-02-282,178$9.35
$20.36kBuy
Brett A. GrimaudSVP GEN COUNSEL AND SECRETARY2025-02-2014,534$9.66
$140.40kSell
Aziz SawafSVP CHIEF FINANCIAL OFFICER2025-02-2013,751$9.66
$132.83kSell
Aine MillerSVP DEV HEAD OF IRE OFFICE2025-02-2011,295$9.66
$109.11kSell
Rick E. WinninghamCHIEF EXECUTIVE OFFICER2025-02-2035,129$9.66
$339.35kSell
Rhonda FarnumSVP COMM MEDICAL AFFAIRS2025-02-2015,810$9.66
$152.72kSell
Rhonda FarnumSVP COMM MEDICAL AFFAIRS2025-01-214,000$9.00
$36.00kSell
Rick E. WinninghamCHIEF EXECUTIVE OFFICER2024-11-2015,997$9.97
$159.49kSell
Rhonda FarnumSVP COMM MEDICAL AFFAIRS2024-11-209,178$9.97
$91.50kSell
Brett A. GrimaudSVP GEN COUNSEL AND SECRETARY2024-11-209,268$9.97
$92.40kSell

1 of 3

TBPH insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TBPH insiders and whales buy or sell their stock.

TBPH Shareholders

What type of owners hold Theravance Biopharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Eli Samaha36.43%18,022,500$155.35MInsider
Glaxosmithkline PLC19.50%9,644,807$83.14MInsider
Madison Avenue Partners LP19.23%9,511,150$81.99MInstitution
Weiss Asset Management LP15.07%7,457,060$64.28MInstitution
Weiss Asset Management LP15.07%7,457,060$64.28MInsider
Newtyn Management LLC9.62%4,757,403$41.01MInstitution
Blackrock Inc7.50%3,712,303$32.00MInstitution
Irenic Capital Management LP5.58%2,760,948$23.80MInstitution
Vanguard Group Inc4.06%2,010,544$17.33MInstitution
Rick E. Winningham3.79%1,874,611$16.16MInsider

1 of 3

TBPH vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TBPH50.89%49.11%Net BuyingNet Selling
MRVI47.85%52.15%Net SellingNet Selling
SAGE69.58%30.42%Net SellingNet Selling
MGTX53.87%46.13%Net BuyingNet Selling
URGN78.35%21.65%Net SellingNet Selling
View Top Biotech Stocks

Theravance Biopharma Stock Ownership FAQ

Who owns Theravance Biopharma?

Theravance Biopharma (NASDAQ: TBPH) is owned by 90.74% institutional shareholders, 87.56% Theravance Biopharma insiders, and 0.00% retail investors. Eli Samaha is the largest individual Theravance Biopharma shareholder, owning 18.02M shares representing 36.43% of the company. Eli Samaha's Theravance Biopharma shares are currently valued at $164.55M.

If you're new to stock investing, here's how to buy Theravance Biopharma stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.